Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine

被引：0
|
作者：
Yoshinori Ito
Yohei Osaki
Nahomi Tokudome
Tsutomu Sugihara
Shunji Takahashi
Takuji Iwase
Kiyohiko Hatake
机构：
[1] The Cancer Institute of Japanese Foundation for Cancer Research,Department of Medical Oncology
[2] Cancer Institute Hospital,Department of Breast Oncology
[3] Japanese Foundation for Cancer Research,undefined
来源：
Breast Cancer | 2009年 / 16卷
关键词：
S-1; Capecitabine; Taxane; Anthracycline; Metastatic breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：126 / 131
页数：5
相关论文
共 50 条
  • [41] Oral etoposide in heavily pretreated metastatic breast cancer: a retrospective analysis of efficacy and safety
    Giannone, G.
    Milani, A.
    Ghisoni, E.
    Genta, S.
    Mittica, G.
    Montemurro, F.
    Valabrega, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [42] Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer
    Liu, Xiu
    Ma, Xiaoting
    Ou, Kai
    Wang, Qi
    Gao, Lizhen
    Yang, Lin
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 277 - 289
  • [43] Efficacy and Safety of S-1 in Patients with Metastatic Breast Cancer: Retrospective Review in a Single Institution
    Hara, Fumikata
    Kiyoto, Sachiko
    Takahashi, Mina
    Takabatake, Daisuke
    Takashima, Seiki
    Aogi, Kenjiro
    Ohsumi, Shozo
    Takashima, Shigemitsu
    ONCOLOGY, 2010, 79 (3-4) : 273 - 277
  • [44] A pilot study of sunitinib in Chinese patients with heavily pretreated metastatic breast cancer
    Wu, S.
    Zhao, X.
    Sun, B.
    Du, M.
    Wang, T.
    Zhang, S.
    Song, S.
    Jiang, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] CLINICAL EXPERIENCE WITH METRONOMIC CHEMOTHERAPY IN HEAVILY PRETREATED METASTATIC BREAST CANCER PATIENTS
    Gavila, J.
    Guerrero, A.
    Ruiz, A.
    Climent, M. A.
    Poveda, A.
    Guillem, V.
    Ruiz, N.
    ANNALS OF ONCOLOGY, 2008, 19 : 74 - 74
  • [46] Eribulin monotherapy in heavily pretreated metastatic breast cancer patients in real life
    Sari, Murat
    Saip, Pinar
    INDIAN JOURNAL OF CANCER, 2020, 57 (01) : 55 - 61
  • [47] Chemotherapy options for patients suffering from heavily pretreated metastatic breast cancer
    Jerusalem, Guy
    Rorive, Andree
    Collignon, Joelle
    FUTURE ONCOLOGY, 2015, 11 (12) : 1775 - 1789
  • [48] Preliminary efficacy and tolerance results of docetaxel (taxotere) (TXT) in heavily pretreated metastatic breast cancer patients (MBC)
    Chahine, A
    Trandafir, L
    Errihani, H
    DesGuetz, G
    Musset, M
    Jasmin, C
    Cvitkovic, E
    Misset, JL
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 382 - 382
  • [49] Phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pretreated patients with metastatic colorectal cancer.
    Yamaguchi, Kazuhisa
    Taniguchi, Hiroya
    Komori, Azusa
    Narita, Yukiya
    Uegaki, Shiori
    Nitta, Sohei
    Nomura, Motoo
    Kadowaki, Shigenori
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [50] Efficacy and safety of palbociclib in heavily pretreated patients with HR+/HER2-metastatic breast cancer
    Ban, Marija
    Mise, Branka Petric
    Majic, Ana
    Drazic, Ivanka
    Vrdoljak, Eduard
    FUTURE ONCOLOGY, 2018, 14 (06) : 537 - 544
12345